<DOC>
	<DOC>NCT01900678</DOC>
	<brief_summary>The objective of this investigation is to evaluate whether pulmonary vein isolation using the VytronUS ablation system is safe and effective acutely and at 3 months.</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Age 18 to 70 years old. Recurrent symptomatic paroxysmal atrial fibrillation refractory to at least one antiarrhythmic drug. Prior pulmonary vein isolation Presence of intracardiac thrombus Indication of inaccessible pulmonary or cardiac anatomy Myocardial infarction, PCI, or cardiac surgery in prior three months Moderate to severe valvular disease or prior valve replacement NYHA Class IV LVEF &lt; 40% Previous stroke or TIA Serum creatinine &gt; 2.5mg/dL or allergy to intravenous contrast agents Existing bleeding diathesis or history of complications with anticoagulation therapy Women who are nursing, pregnant, or trying to become pregnant Subjects unwilling or unable to provide consent Participation in a drug or device trial that would prevent completion of required study procedures Active implantable devices Major organ system disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>